Although I do not routinely measure longitudinal change in body composition or bone mass in people taking GLP-1s, mostly because of the cost of DXA scans, significant muscle or bone loss are two objective manifestations of excessive weight loss that should lead to stopping or slowing treatment
Brain Res 1717:8694 Dutta D, Mohanakumar KP (2015) Tea and Parkinsons disease: constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits
Dig Dis Sci 1979;24(7):54550
Scientific interest in multi-peptide formulations continues to expand as researchers explore how complementary signaling systems interact across tissue-associated biological processes
Neurochem Res 43:116128 Li RW, Yang C, Sit AS, Kwan YW, Lee SM, Hoi MP, Chan SW, Hausman M, Vanhoutte PM, Leung GP (2014) Uptake and protective effects of ergothioneine in human endothelial cells